From: Antipsychotic polypharmacy in a regional health service: a population-based study
Age (years) | Initial Sample (N = 71,004) | Antipsychotic monotherapy (n = 47,386) | Antipsychotics combined (n = 9,855) | |||
---|---|---|---|---|---|---|
Women N(%) | Men N(%) | Women N(%) | Men N(%) | Women N(%) | Men N(%) | |
19-40 | 6,144 (15.6) | 10,808 (34.1) | 3,504 (12.6) | 5,908 (30.1) | 1,153 (27.8) | 2,517 (44.1) |
41-60 | 10,242 (26.0) | 9,843 (31.1) | 6,589 (23.7) | 5,697 (29.0) | 1,560 (37.7) | 2,297 (40.2) |
61-80 | 12,108 (30.8) | 7,455 (23.5) | 9,277 (33.4) | 5,421 (27.6) | 900 (21.7) | 727 (12.7) |
>80 | 10,824 (27.5) | 3,580 (11.3) | 8,379 (30.2) | 2,611 (13.3) | 529 (12.8) | 172 (3.0) |
Total | 39,318 (55.4) | 31,686 (44.6) | 27,749 (58.6) | 19,637 (41.4) | 4,142 (42.0) | 5,713 (58.0) |